Clinical Features and Risk Factors Associated With Worse Outcome in Patients Hospitalized for Covid-19 Pneumonia
1 other identifier
observational
100
1 country
1
Brief Summary
The aim of the research is to improve patient management by rapidly identifying, based on the terrain and clinical and biological characteristics, those patients likely to present a severe form of ARDS at risk of leading to intensive care
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Apr 2020
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 9, 2020
CompletedFirst Submitted
Initial submission to the registry
April 20, 2020
CompletedFirst Posted
Study publicly available on registry
April 24, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 9, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
January 9, 2021
CompletedDecember 28, 2020
April 1, 2020
9 months
April 20, 2020
December 24, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Identification of risk factors for severity (death or transfer to resuscitation) of Covid-19 infection
Files analysed retrospectively from March 1st, 2020 to April 15, 2020 will be examined]
Eligibility Criteria
Adult Patients with Covid-19
You may qualify if:
- Major patient (≥18 years of age)
- Admitted in March 2020 for confirmed Covid-19 lung disease (nasopharyngeal smear or sputum with SARS-CoV-2 positive PCR).
You may not qualify if:
- Patient who has expressed opposition to participation in the study.
- Mild forms of infection that do not require hospitalization,
- Subject under safeguard of justice
- Subject under guardianship or trusteeship
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Service des Maladies Infectieuses et Tropicales
Strasbourg, 67091, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- OTHER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 20, 2020
First Posted
April 24, 2020
Study Start
April 9, 2020
Primary Completion
January 9, 2021
Study Completion
January 9, 2021
Last Updated
December 28, 2020
Record last verified: 2020-04